Product Information
LISINOPRIL 5 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0143 per EA under NDC 68180051330. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Sep 9, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180051330
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077321FDA Approved
9/9/2005
TE Code
AB
On Market Since
1/13/2006
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL 5 MG TABLET has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0143 per EA |
|---|---|
| All-time high | $0.0150 (Jan 14, 2026) |
| All-time low | $0.0143 (Sep 23, 2026) |
| 52-week high | $0.0150 |
| 52-week low | $0.0143 |
| Median price | $0.0148 |
| Average price | $0.0148 |
| Largest weekly change | -3.2% (Sep 23, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lisinopril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LISINOPRIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 5 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0143 per EA (NDC 68180051330), effective Sep 30, 2026.
How has the price of LISINOPRIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LISINOPRIL 5 MG TABLET has declined 4.8%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for LISINOPRIL 5 MG TABLET?
Since Dec 17, 2025, the NADAC for LISINOPRIL 5 MG TABLET has ranged from a low of $0.0143 (Sep 23, 2026) to a high of $0.0150 (Jan 14, 2026), with a median of $0.0148 per EA.
Are there cheaper alternatives to LISINOPRIL 5 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL 5 MG TABLET?
LISINOPRIL 5 MG TABLET (NDC 68180051330) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.